UB Paderborn / Katalog / Suche / in CDI

Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin

The Journal of dermatological treatment, 2023-12, Vol.34 (1), p.2147391-2147391

2023

Volltextzugriff (PDF)

Efficacy and tolerability of three topical acne treatments by body mass index: post hoc analysis including overweight and obese patients

The Journal of dermatological treatment, 2022-08, Vol.33 (6), p.2790-2799

2022

Volltextzugriff (PDF)

50 Years of Topical Retinoids for Acne: Evolution of Treatment

American journal of clinical dermatology, 2021-05, Vol.22 (3), p.315-327

2021

Volltextzugriff (PDF)

Novel Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Race/Ethnicity

Journal of drugs in dermatology, 2020-07, Vol.19 (7), p.727

2020

Volltextzugriff (PDF)

Allergic Skin Disease: Major Highlights and Recent Advances

The Medical clinics of North America, 2009-11, Vol.93 (6), p.1211-1224

2009

Volltextzugriff (PDF)

An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris

Journal of drugs in dermatology, 2014-09, Vol.13 (9), p.1083

2014

Volltextzugriff (PDF)

Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population

Journal of drugs in dermatology, 2019-01, Vol.18 (1), p.32

2019

Volltextzugriff (PDF)

Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: A Safe and Effective Acne Therapy in All Skin Phototypes

Journal of drugs in dermatology, 2017-06, Vol.16 (6), p.574

2017

Volltextzugriff (PDF)

Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial

Journal of drugs in dermatology, 2018-01, Vol.17 (1), p.97

2018

Volltextzugriff (PDF)

Influence of Season on Efficacy and Tolerability of Tazarotene 0.045% Lotion for the Treatment of Acne

The Journal of clinical and aesthetic dermatology, 2023-09, Vol.16 (9), p.42-45

2023

Volltextzugriff (PDF)

Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and benzoyl peroxide (3.75%) aqueous gel in moderate or severe adolescent acne vulgaris

The Journal of clinical and aesthetic dermatology, 2015-05, Vol.8 (5), p.28-32

Cook-Bolden, Fran E

2015

Volltextzugriff (PDF)

Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel

Journal of drugs in dermatology, 2012-04, Vol.11 (4), p.455

Cook-Bolden, Fran E

2012

Volltextzugriff (PDF)

Results of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne Vulgaris

Journal of drugs in dermatology, 2016-12, Vol.15 (12), p.1496

2016

Volltextzugriff (PDF)

The study of skin of color in dermatology

Journal of drugs in dermatology, 2012-04, Vol.11 (4), p.448

Cook-Bolden, Fran E

2012

Volltextzugriff (PDF)

Emerging Issues in Adult Female Acne

The Journal of clinical and aesthetic dermatology, 2017-01, Vol.10 (1), p.37-46

2017

Volltextzugriff (PDF)

Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 Trials

The Journal of clinical and aesthetic dermatology, 2016-10, Vol.9 (10), p.18-27

2016

Volltextzugriff (PDF)

42077 Trifarotene in Context: Exploring the Acne Burden in Latin America

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB244-AB244

2023

Volltextzugriff (PDF)

Defining pseudofolliculitis barbae in 2001: A review of the literature and current trends

Journal of the American Academy of Dermatology, 2002-02, Vol.46 (2), p.S113-S119

2002

Volltextzugriff (PDF)

Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial

Journal of drugs in dermatology, 2011-08, Vol.10 (8), p.885

2011

Volltextzugriff (PDF)

Topically applied physiologically balanced growth factors: a new paradigm of skin rejuvenation

Journal of drugs in dermatology, 2009-05, Vol.8 (5 Suppl Skin Rejuenation), p.4

2009

Volltextzugriff (PDF)

27615 Impact of body mass index (BMI) on efficacy of three topical acne treatments in patients with moderate-to-severe acne

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.AB156-AB156

2021

Volltextzugriff (PDF)

Tolerability of tretinoin lotion 0.05% for moderate to severe acne vulgaris: a post hoc analysis in a black population

Cutis (New York, N.Y.), 2020-07, Vol.106 (1), p.45-50;E1

2020

Volltextzugriff (PDF)

Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitis

Journal of drugs in dermatology, 2007-02, Vol.6 (2), p.175

2007

Volltextzugriff (PDF)

Safety of Tazarotene 0.045% Lotion and Hyperpigmentation Improvements in Black Participants With Moderate-to-Severe Acne

Skin (Milwood, N.Y.), 2023-07, Vol.7 (4), p.s221

2023

Volltextzugriff (PDF)

27832 Impact of facial and truncal acne on quality of life (QoL) in female adults: A multicountry population-based survey

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.AB163-AB163

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin

Efficacy and tolerability of three topical acne treatments by body mass index: post hoc analysis including overweight and obese patients

50 Years of Topical Retinoids for Acne: Evolution of Treatment

Novel Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Race/Ethnicity

Allergic Skin Disease: Major Highlights and Recent Advances

An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris

Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population

Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: A Safe and Effective Acne Therapy in All Skin Phototypes

Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial

Influence of Season on Efficacy and Tolerability of Tazarotene 0.045% Lotion for the Treatment of Acne

Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and benzoyl peroxide (3.75%) aqueous gel in moderate or severe adolescent acne vulgaris

Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel

Results of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne Vulgaris

The study of skin of color in dermatology

Emerging Issues in Adult Female Acne

Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 Trials

42077 Trifarotene in Context: Exploring the Acne Burden in Latin America

Defining pseudofolliculitis barbae in 2001: A review of the literature and current trends

Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial

Topically applied physiologically balanced growth factors: a new paradigm of skin rejuvenation

27615 Impact of body mass index (BMI) on efficacy of three topical acne treatments in patients with moderate-to-severe acne

Tolerability of tretinoin lotion 0.05% for moderate to severe acne vulgaris: a post hoc analysis in a black population

Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitis

Safety of Tazarotene 0.045% Lotion and Hyperpigmentation Improvements in Black Participants With Moderate-to-Severe Acne

27832 Impact of facial and truncal acne on quality of life (QoL) in female adults: A multicountry population-based survey

Suchergebnisse filtern